ECOG-4599

NCT00021060 📎

Regimen

Experimental
paclitaxel+carboplatin+bevacizumab
Control
paclitaxel+carboplatin

Population

Advanced non-squamous NSCLC, no brain mets, no hemoptysis

Key finding

mOS 12.3 vs 10.3 mo, HR 0.79 (0.67-0.92); first biologic on doublet in 1L non-sq NSCLC

Source: PMID 17167137

Timeline

  • Enrollment start: 2002-08 📎

Guideline citations

  • NCCN NSCLC Version 5.2026 (p.169)